WeVote
Log In

Bill

Bill

HB 3910

False advertising in health care; term; deceptive act; enforcement; penalties; effective date.

2026 Regular Session Introduced by Mickey Dollens

Oklahoma bill establishes penalties for false health care advertising, classifying deceptive marketing claims as enforceable violations with specified consequences for violators.

Referred to Civil Judiciary
0
WeVote Research Nonpartisan
Bill Summary · HB 3910

Legislative bill overview

HB 3910 addresses false advertising practices in the healthcare industry by establishing definitions, enforcement mechanisms, and penalties for deceptive health-related advertisements. The bill classifies such false advertising as a deceptive act under Oklahoma law, creating legal liability for violators. It provides the state with enforcement tools and specifies consequences for healthcare providers and advertisers who mislead consumers about services, treatments, or products.

Why is this important

Healthcare fraud through false advertising directly harms consumers who may make medical decisions or financial commitments based on misleading claims. Establishing clear penalties and enforcement mechanisms can deter predatory practices, protect vulnerable populations (elderly, chronically ill), and reduce healthcare fraud costs that ultimately affect insurance premiums and public health resources. Strong enforcement also levels the playing field for honest healthcare providers competing against those using deceptive marketing.

Potential points of contention

  • Definition scope: Determining what constitutes "false advertising" versus permissible puffery, marketing claims about emerging treatments, or off-label uses could be contentious and subject to court interpretation
  • Enforcement burden: Questions about which agencies enforce the law and whether small providers or platforms have adequate resources to comply without creating barriers to legitimate healthcare communication
  • Free speech concerns: First Amendment advocates may argue overly broad definitions could restrict protected speech about alternative medicines, experimental treatments, or providers' qualifications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.